Published in Obstet Gynecol on February 01, 2014
Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies. PLoS One (2015) 0.82
Development: Hypospadias linked with maternal hypertension. Nat Rev Endocrinol (2014) 0.75
Is preeclampsia associated with fetal malformation? A review and report of original research. J Matern Fetal Neonatal Med (2014) 0.75
Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA (2002) 10.03
Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol (2002) 9.76
Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med (2006) 5.91
Screening for intimate partner violence in health care settings: a randomized trial. JAMA (2009) 4.80
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med (2007) 4.25
Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol (2011) 4.14
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med (2007) 3.79
Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2003) 3.75
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol (2011) 3.42
Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol (2005) 3.37
Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics (2002) 2.90
Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr (2009) 2.90
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol (2007) 2.69
Recent trends in use of herbal and other natural products. Arch Intern Med (2005) 2.65
Trends in the sensitivity, positive predictive value, false-positive rate, and comparability ratio of hospital discharge diagnosis codes for acute myocardial infarction in four US communities, 1987-2000. Am J Epidemiol (2004) 2.59
Approaches to screening for intimate partner violence in health care settings: a randomized trial. JAMA (2006) 2.50
Prevalence and characteristics of opioid use in the US adult population. Pain (2008) 2.49
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
Identification of phthalates in medications and dietary supplement formulations in the United States and Canada. Environ Health Perspect (2011) 2.40
Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod (2008) 2.38
Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics (2003) 2.35
Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts. Occup Environ Med (2012) 2.35
Increased prevalence of renal and urinary tract anomalies in children with congenital hypothyroidism. J Pediatr (2008) 2.20
Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol (2012) 2.14
A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet (2012) 2.12
Effects of partner notification on reducing gonorrhea incidence rate. Sex Transm Dis (2007) 2.07
Maternal obesity and congenital heart defects: a population-based study. Am J Clin Nutr (2010) 2.06
Sensitivity and specificity of computerized algorithms to classify gestational periods in the absence of information on date of conception. Am J Epidemiol (2008) 1.97
Alcohol consumption by women before and during pregnancy. Matern Child Health J (2008) 1.94
Control selection and participation in an ongoing, population-based, case-control study of birth defects: the National Birth Defects Prevention Study. Am J Epidemiol (2009) 1.93
Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet Gynecol (2011) 1.89
Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am J Obstet Gynecol (2005) 1.78
Induced Abortions and the Risk of Preeclampsia Among Nulliparous Women. Am J Epidemiol (2015) 1.76
Periconceptional use of opioids and the risk of neural tube defects. Obstet Gynecol (2013) 1.76
Reduced risks of neural tube defects and orofacial clefts with higher diet quality. Arch Pediatr Adolesc Med (2011) 1.73
Maternal exposure to methotrexate and birth defects: a population-based study. Am J Med Genet A (2014) 1.70
Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol (2008) 1.69
Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J (2009) 1.68
Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports. BMJ (2015) 1.68
Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol (2011) 1.66
Maternal asthma medication use and the risk of gastroschisis. Am J Epidemiol (2008) 1.62
Residential mobility during pregnancy and the potential for ambient air pollution exposure misclassification. Environ Res (2009) 1.56
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot. Epidemiology (2014) 1.54
Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health (2006) 1.51
In vitro fertilization is associated with an increase in major birth defects. Fertil Steril (2005) 1.51
Erythromycin use during pregnancy in relation to pyloric stenosis. Am J Obstet Gynecol (2002) 1.50
Maternal smoking and congenital heart defects. Pediatrics (2008) 1.49
Medications as a potential source of exposure to phthalates in the U.S. population. Environ Health Perspect (2008) 1.45
Emergency care of urban women with sexually transmitted infections: time to address deficiencies. Sex Transm Dis (2009) 1.42
Medication use among children <12 years of age in the United States: results from the Slone Survey. Pediatrics (2009) 1.41
Antiherpetic medication use and the risk of gastroschisis: findings from the National Birth Defects Prevention Study, 1997-2007. Paediatr Perinat Epidemiol (2013) 1.40
Maternal butalbital use and selected defects in the national birth defects prevention study. Headache (2013) 1.39
Black women's health: the effect of perceived racism and intimate partner violence. Violence Against Women (2006) 1.39
Using bayesian models to assess the effects of under-reporting of cannabis use on the association with birth defects, national birth defects prevention study, 1997-2005. Paediatr Perinat Epidemiol (2014) 1.39
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
Cough and cold medication use by US children, 1999-2006: results from the slone survey. Pediatrics (2008) 1.36
Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med (2008) 1.36
The National Down Syndrome Project: design and implementation. Public Health Rep (2007) 1.35
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35
Selective serotonin reuptake inhibitor use and risk of gestational hypertension. Am J Psychiatry (2009) 1.34
Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol (2007) 1.34
Anencephaly and spina bifida among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2009) 1.31
Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine (2011) 1.30
Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol (2010) 1.28
The National Birth Defects Prevention Study: A review of the methods. Birth Defects Res A Clin Mol Teratol (2015) 1.28
Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol (2002) 1.27